Barclays’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $616K | Sell |
35,241
-14,030
| -28% | -$278K | ﹤0.01% | 3064 |
|
|
2025
Q4 | $967K | Buy |
49,271
+18,068
| +58% | +$375K | ﹤0.01% | 3450 |
|
|
2025
Q3 | $860K | Sell |
31,203
-7,410
| -19% | -$228K | ﹤0.01% | 3457 |
|
|
2025
Q2 | $1.18M | Buy |
38,613
+9,402
| +32% | +$267K | ﹤0.01% | 3228 |
|
|
2025
Q1 | $788K | Sell |
29,211
-1,856
| -6% | -$58.8K | ﹤0.01% | 3251 |
|
|
2024
Q4 | $1.11M | Buy |
31,067
+3,330
| +12% | +$125K | ﹤0.01% | 3308 |
|
|
2024
Q3 | $1.05M | Buy |
27,737
+14,647
| +112% | +$602K | ﹤0.01% | 3320 |
|
|
2024
Q2 | $592K | Sell |
13,090
-5,950
| -31% | -$274K | ﹤0.01% | 2942 |
|
|
2024
Q1 | $923K | Sell |
19,040
-7,662
| -29% | -$375K | ﹤0.01% | 3177 |
|
|
2023
Q4 | $1.43M | Buy |
26,702
+12,143
| +83% | +$614K | ﹤0.01% | 3176 |
|
|
2023
Q3 | $853K | Buy |
14,559
+216
| +2% | +$13.5K | ﹤0.01% | 2453 |
|
|
2023
Q2 | $904K | Sell |
14,343
-299
| -2% | -$19K | ﹤0.01% | 2374 |
|
|
2023
Q1 | $921K | Sell |
14,642
-3,612
| -20% | -$216K | ﹤0.01% | 2791 |
|
|
2022
Q4 | $971K | Buy |
18,254
+15,060
| +472% | +$816K | ﹤0.01% | 2830 |
|
|
2022
Q3 | $179K | Sell |
3,194
-2,030
| -39% | -$134K | ﹤0.01% | 3269 |
|
|
2022
Q2 | $379K | Sell |
5,224
-4,320
| -45% | -$322K | ﹤0.01% | 3052 |
|
|
2022
Q1 | $758K | Sell |
9,544
-8,071
| -46% | -$728K | ﹤0.01% | 2607 |
|
|
2021
Q4 | $1.78M | Sell |
17,615
-2,922
| -14% | -$291K | ﹤0.01% | 2456 |
|
|
2021
Q3 | $1.89M | Buy |
20,537
+4,705
| +30% | +$453K | ﹤0.01% | 2399 |
|
|
2021
Q2 | $1.62M | Sell |
15,832
-7,291
| -32% | -$732K | ﹤0.01% | 2337 |
|
|
2021
Q1 | $2.26M | Buy |
23,123
+2,635
| +13% | +$240K | ﹤0.01% | 2173 |
|
|
2020
Q4 | $1.58M | Sell |
20,488
-472
| -2% | -$36.5K | ﹤0.01% | 2430 |
|
|
2020
Q3 | $1.54M | Buy |
20,960
+4,962
| +31% | +$398K | ﹤0.01% | 2321 |
|
|
2020
Q2 | $1.17M | Buy |
15,998
+1,751
| +12% | +$137K | ﹤0.01% | 2618 |
|
|
2020
Q1 | $823K | Sell |
14,247
-6,962
| -33% | -$484K | ﹤0.01% | 3156 |
|
|
2019
Q4 | $1.67M | Sell |
21,209
-3,451
| -14% | -$254K | ﹤0.01% | 3189 |
|
|
2019
Q3 | $1.69M | Buy |
24,660
+398
| +2% | +$26.7K | ﹤0.01% | 3079 |
|
|
2019
Q2 | $1.93M | Sell |
24,262
-2,325
| -9% | -$184K | ﹤0.01% | 2963 |
|
|
2019
Q1 | $2.23M | Buy |
26,587
+14,002
| +111% | +$1.46M | ﹤0.01% | 2455 |
|
|
2018
Q4 | $1.48M | Sell |
12,585
-1,858
| -13% | -$215K | ﹤0.01% | 2710 |
|
|
2018
Q3 | $1.74M | Buy |
14,443
+6,427
| +80% | +$798K | ﹤0.01% | 3040 |
|
|
2018
Q2 | $925K | Sell |
8,016
-2,427
| -23% | -$266K | ﹤0.01% | 3370 |
|
|
2018
Q1 | $898K | Buy |
10,443
+3,105
| +42% | +$240K | ﹤0.01% | 3340 |
|
|
2017
Q4 | $543K | Buy |
7,338
+717
| +11% | +$48K | ﹤0.01% | 3738 |
|
|
2017
Q3 | $383K | Sell |
6,621
-23,195
| -78% | -$1.37M | ﹤0.01% | 3871 |
|
|
2017
Q2 | $1.91M | Buy |
29,816
+18,615
| +166% | +$1.15M | ﹤0.01% | 2290 |
|
|
2017
Q1 | $646K | Sell |
11,201
-20,632
| -65% | -$1.23M | ﹤0.01% | 3150 |
|
|
2016
Q4 | $1.95M | Buy |
31,833
+13,285
| +72% | +$866K | ﹤0.01% | 2147 |
|
|
2016
Q3 | $1.28M | Sell |
18,548
-3,282
| -15% | -$217K | ﹤0.01% | 2394 |
|
|
2016
Q2 | $1.22M | Sell |
21,830
-13,034
| -37% | -$786K | ﹤0.01% | 2439 |
|
|
2016
Q1 | $2.11M | Buy |
34,864
+32,144
| +1,182% | +$1.89M | ﹤0.01% | 1878 |
|
|
2015
Q4 | $173K | Sell |
2,720
-2,816
| -51% | -$183K | ﹤0.01% | 4018 |
|
|
2015
Q3 | $371K | Buy |
5,536
+5,026
| +985% | +$355K | ﹤0.01% | 3618 |
|
|
2015
Q2 | $35K | Buy |
510
+164
| +47% | +$10.4K | ﹤0.01% | 5372 |
|
|
2015
Q1 | $19K | Sell |
346
-304
| -47% | -$15.6K | ﹤0.01% | 5868 |
|
|
2014
Q4 | $33K | Sell |
650
-990
| -60% | -$48.6K | ﹤0.01% | 6010 |
|
|
2014
Q3 | $61K | Sell |
1,640
-97,082
| -98% | -$3.5M | ﹤0.01% | 5721 |
|
|
2014
Q2 | $3.85M | Buy |
98,722
+87,218
| +758% | +$3.24M | ﹤0.01% | 1997 |
|
|
2014
Q1 | $432K | Buy |
11,504
+10,672
| +1,283% | +$373K | ﹤0.01% | 4083 |
|
|
2013
Q4 | $31K | Buy |
832
+224
| +37% | +$8.57K | ﹤0.01% | 6477 |
|
|
2013
Q3 | $26K | Sell |
608
-176
| -22% | -$7.06K | ﹤0.01% | 6415 |
|
|
2013
Q2 | $29K | Buy |
+784
| New | +$23.8K | ﹤0.01% | 6649 |
|
Other funds holding USNA
NCM
VCM
VPM
Barclays's USNA Position: Q1 2026 in Review
Barclays reduced its Usana Health Sciences (USNA) stake by 28% in Q1 2026, selling an estimated $278K and leaving 35,241 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #3064.
Barclays first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.85M in Q2 2014. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- Barclays held 35,241 shares of Usana Health Sciences worth $616K as of Q1 2026.
- Barclays sold 14,030 Usana Health Sciences shares in Q1 2026, an estimated $278K.
- Usana Health Sciences made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3064 holding.
- Barclays first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
- Barclays's Usana Health Sciences position peaked at $3.85M in Q2 2014.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.